Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer

Michel van Gelder; Ariane Vanclee; Catharina H. M. J. van Elssen; Pierre Hupperets; Lotte Wieten; Gerard M. Bos

doi:10.1007/s10549-016-4067-6

Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer

Michel van Gelder^*, Ariane Vanclee, Catharina H. M. J. van Elssen, Pierre Hupperets, Lotte Wieten, Gerard M. Bos

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	421-433
Number of pages	13
Journal	Breast Cancer Research and Treatment
Volume	161
Issue number	3
DOIs	https://doi.org/10.1007/s10549-016-4067-6
Publication status	Published - Feb 2017

Keywords

4T1
Breast cancer
Immunotherapy
Alloreactive NK cell
Hematopoietic stem cell transplantation
KIR-LIGAND INCOMPATIBILITY
VERSUS-LEUKEMIA ACTIVITY
ACUTE MYELOID-LEUKEMIA
MHC CLASS-I
T-CELLS
TUMOR-CELLS
ADOPTIVE IMMUNOTHERAPY
ACTIVATING RECEPTORS
HEMATOPOIETIC SCT
SUPPRESSOR-CELLS

Access to Document

10.1007/s10549-016-4067-6

Cite this

van Gelder, M., Vanclee, A., van Elssen, C. H. M. J., Hupperets, P., Wieten, L., & Bos, G. M. (2017). Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer. Breast Cancer Research and Treatment, 161(3), 421-433. https://doi.org/10.1007/s10549-016-4067-6

@article{ba8a0b72465e4dedb9472bd11aacffa1,

title = "Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer",

keywords = "4T1, Breast cancer, Immunotherapy, Alloreactive NK cell, Hematopoietic stem cell transplantation, KIR-LIGAND INCOMPATIBILITY, VERSUS-LEUKEMIA ACTIVITY, ACUTE MYELOID-LEUKEMIA, MHC CLASS-I, T-CELLS, TUMOR-CELLS, ADOPTIVE IMMUNOTHERAPY, ACTIVATING RECEPTORS, HEMATOPOIETIC SCT, SUPPRESSOR-CELLS",

author = "{van Gelder}, Michel and Ariane Vanclee and {van Elssen}, {Catharina H. M. J.} and Pierre Hupperets and Lotte Wieten and Bos, {Gerard M.}",

year = "2017",

month = feb,

doi = "10.1007/s10549-016-4067-6",

language = "English",

volume = "161",

pages = "421--433",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer, Cham",

number = "3",

}

Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer. / van Gelder, Michel; Vanclee, Ariane; van Elssen, Catharina H. M. J.; Hupperets, Pierre; Wieten, Lotte ; Bos, Gerard M.

In: Breast Cancer Research and Treatment, Vol. 161, No. 3, 02.2017, p. 421-433.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer

AU - van Gelder, Michel

AU - Vanclee, Ariane

AU - van Elssen, Catharina H. M. J.

AU - Hupperets, Pierre

AU - Wieten, Lotte

AU - Bos, Gerard M.

PY - 2017/2

Y1 - 2017/2

KW - 4T1

KW - Breast cancer

KW - Immunotherapy

KW - Alloreactive NK cell

KW - Hematopoietic stem cell transplantation

KW - KIR-LIGAND INCOMPATIBILITY

KW - VERSUS-LEUKEMIA ACTIVITY

KW - ACUTE MYELOID-LEUKEMIA

KW - MHC CLASS-I

KW - T-CELLS

KW - TUMOR-CELLS

KW - ADOPTIVE IMMUNOTHERAPY

KW - ACTIVATING RECEPTORS

KW - HEMATOPOIETIC SCT

KW - SUPPRESSOR-CELLS

U2 - 10.1007/s10549-016-4067-6

DO - 10.1007/s10549-016-4067-6

M3 - Article

VL - 161

SP - 421

EP - 433

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -